IRC
CTMX icon

Investors Research Corp’s CytomX Therapeutics CTMX Stock Holding History

Investors Research Corp’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.52K Buy
+3,134
New +$10.5K ﹤0.01% 555

Other funds holding CTMX

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Investors Research Corp's CTMX Position: Q3 2026 in Review

Investors Research Corp opened a new position in CytomX Therapeutics (CTMX) in Q3 2026: 3,134 shares worth $8.52K. The stake represents ﹤0.01% of the portfolio and ranks #555 among its holdings.

3 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.

  • Investors Research Corp held 3,134 shares of CytomX Therapeutics worth $8.52K as of Q3 2026.
  • CytomX Therapeutics was a new Investors Research Corp position in Q3 2026.
  • CytomX Therapeutics made up ﹤0.01% of Investors Research Corp's portfolio in Q3 2026, its #555 holding.
  • 3 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.